首页> 外国专利> COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES

COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES

机译:免疫缺陷治疗恶性和非恶性血液病的组合物和方法

摘要

This invention provides a method for depleting a subject's hematopoietic stem cells that includes administering to the subject an effective amount of a radiolabeled antibody against CD34, CD117, or CD135, where preferred radiolabels include 131I and 225Ac. This invention also provides a method for treating a subject afflicted with a non-cancerous disorder treatable via genetically edited cell therapy, where the method includes (i) administering to the subject an amount of the radiolabeled antibody effective to deplete the subject's hematopoietic stem cells, and (ii) after a suitable time period, performing the therapy on the subject to treat the subject's disorder. Finally, this invention provides articles of manufacture for performing the subject methods.
机译:本发明提供了一种消耗受试者的造血干细胞的方法,该方法包括向受试者施用有效量的针对CD34,CD117或CD135的放射性标记的抗体,其中优选的放射性标记包括 131 I和 225 Ac。本发明还提供了一种用于治疗可通过基因编辑细胞疗法治疗的非癌性疾病的受试者的方法,其中该方法包括:(i)向受试者施用一定量的能有效消耗受试者的造血干细胞的放射标记抗体, (ii)在合适的时间段之后,对受试者进行治疗以治疗受试者的疾病。最后,本发明提供了用于执行主题方法的制品。

著录项

  • 公开/公告号WO2020219861A1

    专利类型

  • 公开/公告日2020-10-29

    原文格式PDF

  • 申请/专利权人 ACTINIUM PHARMACEUTICALS INC.;

    申请/专利号WO2020US29790

  • 发明设计人 LUDWIG DALE;

    申请日2020-04-24

  • 分类号A61K35/28;A61P35/02;

  • 国家 WO

  • 入库时间 2022-08-21 11:08:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号